Tissue Diagnostics Market - Industry Analysis, Forecast, and Growth Opportunity

Stratview Research announces the launch of a new research report on the Tissue Diagnostics Market. This Extensive report from Stratview Research, studies the global clinical diagnostics market - tissue over the trend period of 2014 to 2017 and forecast period of 2018 to 2025 under the following segments:
• By Product Type - Consumables, Antibodies, Kits, Reagents, Probes, Instruments, Slide Staining System (Conventional), Scanners, Tissue Processing Systems, Other Methods
• By Technology - Immunochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology, Special Staining
• By Condition - Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), Other Diseases
• By End User - Hospitals, Pharma R&D, Clinics, CRO, Others
• By Region - North America, Western Europe, Asia-Pacific, Latin America, Rest of the World

Click here to request the detailed TOC of the report:
https://www.stratviewresearch.com/toc/406/tissue-diagnostics-market-tissue.html
OR
Request a sample here:
https://www.stratviewresearch.com/Request-Sample/406/tissue-diagnostics-market-tissue.html

Liquid biopsy is becoming a reality
As we approach 2019, liquid biopsy is becoming a reality, for confirmatory diagnosis often repeated biopsies are needed to study the changing tumor and therefore, present a huge challenge to the patient. The process is risk prone, painful as well adds cost to the procedure. It is expected in about two years, liquid biopsy will become an adjunct to tissue biopsy. This technology has proven to be much more effective and detects worsening of a disease condition even before a CT scan, saving unnecessary medical expenses. The future of clinical diagnostics is expected to be far more connected, companies such as GE Healthcare and Roche are collaborating (January 2018) develop integrated digital diagnostics platform to improve oncology and critical care treatment.

Top Market Players
Many multinational and domestic companies are present in this highly attractive segment. Companies like Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Cell Signaling Technology (US), Agilent Technologies (US), Merck (Germany), TissueGnostics (Austria), Sakura Finetek Japan (Japan), Abcam (UK), BD (US), QIAGEN (Netherlands), Sienna Cancer Diagnostics (Australia), Royal Philips (Netherlands), A. Menarini Diagnostics (Italy), Enzo Life Sciences (US), and more are present globally and locally.

Why Stratview Research
Our report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights on the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
• Market structure: Overview, industry life cycle analysis, supply chain analysis
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
• Market trend and forecast analysis
• Market segment trend and forecast
• Competitive landscape and dynamics: Market share, Product portfolio, New product launches, etc.
• Attractive market segments and associated growth opportunities
• Emerging trends
• Strategic growth opportunities for the existing and new players
• Key success factors
• Future outlook

Stratview Research has several high value market reports in the healthcare & life science industry. Please refer to the following link to browse through our reports:
https://www.stratviewresearch.com/market/report/Healthcare-and-Life-Sciences.html

About Stratview Research
Stratview Research is a global market intelligence firm offering a wide range of services including syndicated market reports, consulting, sourcing intelligence, and customer research. We are a trusted brand in the research industry with capability of commissioning complex projects within a short span of time with high level of accuracy.

Stratview Research
400 Renaissance Center,
Suite 2600,
Detroit, Michigan, MI 48243
United States of America
Phone No. +1-313-307-4176
sales@stratviewresearch.com

This release was published on openPR.